These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5952734)

  • 1. Quinacrine effects on the central nervous system.
    Engel GL
    JAMA; 1966 Aug; 197(6):515. PubMed ID: 5952734
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of alcohol on the central nervous system.
    Mendelson JH
    N Engl J Med; 1971 Jan; 284(2):104-5. PubMed ID: 5538626
    [No Abstract]   [Full Text] [Related]  

  • 3. The electrical activity of the brain in a case of atabrine psychosis.
    HALPERN L; STREIFLER M; LASZLO L
    Am J Psychiatry; 1953 Nov; 110(5):366-9. PubMed ID: 13104677
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of quinacrine (atabrine) on the central nervous system; clinical and electroencephalographic studies.
    ENGEL GL; ROMANO J; FERRIS EB
    Arch Neurol Psychiatry; 1947 Sep; 58(3):337-50. PubMed ID: 20265599
    [No Abstract]   [Full Text] [Related]  

  • 5. [Case of psychotic disturbances in the course of atabrine treatment of lamblia infestation].
    Kuzak K
    Pediatr Pol; 1971 May; 46(5):635-7. PubMed ID: 5091776
    [No Abstract]   [Full Text] [Related]  

  • 6. Symptom management.
    O'Connor P
    Adv Neurol; 2006; 98():227-55. PubMed ID: 16400837
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemistry and psychiatry].
    Bickel MH
    Schweiz Med Wochenschr; 1967 Sep; 97(36):1167-73. PubMed ID: 4385790
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of two central nervous system stimulants, MER-22 and S.K.F. #5, on chronic blocked and withdrawn psychotic patients.
    HAGENAUER F; RUDY LH; HIMWICH HE
    Am J Psychiatry; 1957 Mar; 113(9):840. PubMed ID: 13402976
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicity of quinacrine (atabrine) for the central nervous system; an experimental study on human subjects.
    LIDZ T; KAHN RL
    Arch Neurol Psychiatry; 1946 Sep; 56():284-99. PubMed ID: 20999832
    [No Abstract]   [Full Text] [Related]  

  • 10. Insanity due to mepacrine.
    SHRIVASTAVA SK
    Indian Med J; 1947 Jul; 41(7):121. PubMed ID: 20261345
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute mental status changes following intrapleural instillation of quinacrine for traumatic pneumothorax.
    Weingart SN; Hamlett F; Miller BD
    Psychosomatics; 1996; 37(1):74-8. PubMed ID: 8600499
    [No Abstract]   [Full Text] [Related]  

  • 12. The phrenotropic agents.
    CARR CJ; KINNARD WJ
    Int Rec Med Gen Pract Clin; 1957 Sep; 170(9):493-504. PubMed ID: 13491162
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contemporary problems of psychopharmacology].
    MOROZOV VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(2):265-71. PubMed ID: 13443498
    [No Abstract]   [Full Text] [Related]  

  • 14. The action of barbiturates upon liver alcohol dehydrogenase. Their interference with alcohol metabolism.
    Schwarzmann V; Berthaux N
    Biomedicine; 1974 Jan; 21(1):26-9. PubMed ID: 4367420
    [No Abstract]   [Full Text] [Related]  

  • 15. [Central stimulant and depressing pyrimidine derivatives].
    JACOB J
    Experientia; 1951 Sep; 7(9):352-3. PubMed ID: 14879815
    [No Abstract]   [Full Text] [Related]  

  • 16. The implications of psychopharmacology in the etiology and treatment of mental illness.
    KETY SS
    Ann N Y Acad Sci; 1957 Mar; 66(3):836-40. PubMed ID: 13425264
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic products of arachidonic acid in the central nervous system: possible role in mental disorders.
    Mathé AA; Apéria B; Bergman P; Eberhard G; Jerling M; Lindström L; Sääf J; Undén F; Wetterberg L
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():958-62. PubMed ID: 2960211
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxic psychosis following use of quinacrine.
    Lindenmayer JP; Vargas P
    J Clin Psychiatry; 1981 Apr; 42(4):162-4. PubMed ID: 7204361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis.
    Genel F; Erermis S; Aksu G; Ozturk C; Kutukculer N
    Hum Psychopharmacol; 2002 Oct; 17(7):357-9. PubMed ID: 12415556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of the central nervous system.
    Shellenberger MK; Walaszek E
    Prog Neurol Psychiatry; 1970; 25():106-29. PubMed ID: 4395104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.